Early mineralocorticoid receptor antagonism for end-organ protection in hypertension: Implications for disparities and rethinking the timing paradigm. [PDF]
Ezeugwu CO.
europepmc +1 more source
Journal of Diabetes Investigation, Volume 17, Issue 9, Page 1453-1456, September 2026.
wiley +1 more source
Spurious Hyperkalemia Without Hemolysis: A Case-Based Presentation of Preanalytical Errors and Diagnostic Pitfalls. [PDF]
Umińska A +2 more
europepmc +1 more source
Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study. [PDF]
Güven AT +82 more
europepmc +1 more source
Severe hyperkalemia and muscle weakness in HIV-associated <i>Pneumocystis jirovecii</i> pneumonia treated with high-dose trimethoprim-sulfamethoxazole and corticosteroids: A case report. [PDF]
Van An N +3 more
europepmc +1 more source
Fruits, Vegetables, and Legumes: Harnessing the Gut-Kidney Axis in Hypertensive Chronic Kidney Disease. [PDF]
Agustin M +5 more
europepmc +1 more source
Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors. [PDF]
Crum KL, Vaduganathan M, Desai RJ.
europepmc +1 more source
Patient and Clinician Perspectives on Hyperkalemia Management Under Cardio-Kidney-Protective Therapy: A Three-Stakeholder Cross-Sectional Survey. [PDF]
Yi Y, Baek SH, Lee J, Kim S.
europepmc +1 more source
To: Catecholamines and serum potassium alterations in critically ill neonates: a prospective cohort study. [PDF]
Gunasekaran V, Babu TA.
europepmc +1 more source
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort. [PDF]
Özdede M +82 more
europepmc +1 more source

